The ACTA Trial of the Year Awards were established in 2016 and has been traditionally celebrated in International Clinical Trials day in May, as part of a National Tribute and Awards Ceremony. In 2020, the awards were delayed due to COVID-19, and are instead being presented as part of the opening of the Summit.
The awards honour the remarkable Australians who advance our health system by designing, conducting or participating in ground-breaking clinical trials, and promote the importance of clinical trials and the expertise and complexity of work involved. Trials considered for the award are collaboratively developed, multicentre, investigator-driven randomised controlled trials that were designed to improve patient-centred outcomes or healthcare delivery.
In 2020, eleven applications were received for the main Trial of the Year Award, as below. There are currently three main awards and we aim to add further awards in 2021, to recognise industry collaboration and clinical quality registries.
The 2020 ACTA Trial of the Year, ACTA STInG Excellence in Trial Statistics Award and the ACTA Consumer Involvement Awards, will be announced at the the ACTA Summit 2020 on 1 December, 2020, and we hope you will join us.
Registration for the Awards Ceremony and Summit and the live stream of the ceremony has now closed.
Watch the official opening of the 2020 ACTA Summit: Minister’s Address
Sponsors
We are very grateful to the continued support of our event sponsors.
- Gold Sponsors
- NSW Office for Health and Medical Research
- Bellberry Limited
- Clinical Trials 2020: National Tribute and Awards Ceremony Sponsor
- Medicines Australia
- Session Sponsor
- MTPConnect

Latest Resources
-
-
ACTA Masterclass 5: Consumer Engagement
-
ACTA Consumer Reimbursement and Remuneration Policy
-
Webinar recording: ICH GCP E6 (R3) guidelines: What’s New, What’s Changed, What’s Next!
-
ACTA Consumer Remimbursement and Remuneration Policy
-
Webinar recording: APT Virtual Clinic – ACT-GLOBAL Adaptive Platform Trial for Stroke
-
Workshop: How to better develop cross-network collaborations and linkages
-
The processes involved in a Data and Safety Monitoring Board/Committee with special reference to the role of the various statisticians
-
Webinar recording: National Clinical Trials Governance Framework: Update from sites that have been through accreditation
-
ACTA 2022-2023 Annual Report
-
ACTA Whistleblower Policy
-
HEAT webinar recording: Design of economic evaluations along the development process
-
Workshops and Virtual Clinics on Adaptive Platform Trials
-
Webinar recording: APT Virtual Clinic – the BAT and PASSPORT Trials
-
Exploring greater partnership between Clinical Trial Networks, Clinical Quality Registries and Trial Coordinating Centres with Industry
-
Value of clinical trials infographic
-
HEAT Webinar Recording-Flexible survival models and why we (might) need them
-
HEAT Webinar Recording- Use of Administrative Data for Measuring Events and Healthcare Use
-
Recommendations to improve cultural and linguistic diversity in clinical trials
-
Adaptive Platform Trial Summaries
-
Approaches to prioritising research
for clinical trial networks: a scoping review -
HEAT Webinar Recording- Economic Evaluation Alongside Adaptive Trials
-
ACTA 2021-2022 Annual Report
-
Effective strategies to manage data integrity risks webinar
-
The Data Lifecycle: Ethical use of data webinar
-
Transparency in data analyses webinar
-
Economic evaluation alongside cluster trial – webinar recording
-
Development of the Consumer Involvement and Engagement Toolkit
-
Activities supporting the growth of Clinical Trial Networks in Australia
-
Strengthening the capacity, efficiency and effectiveness of Clinical Trials Networks: Activity Overview 2017–2021
-
ACTA 2020-2021 Annual Report
-
MEDIA RELEASE: ACTA appoints Prof Steve Webb as its new Chair and Ian Wilson as Additional Independent Director
-
Official Opening of the 2020 ACTA Summit: Minister’s Address
-
ACTA Year in Review: Financial Year 2019-2020
-
ACTA submission: Parliamentary Inquiry into approval processes for new drugs and novel medical technologies in Australia
-
Statistical Analysis Plan (SAP)
Latest Events
-
ACTA 2025 Clinical Trials and Registries Symposium
-
ACTA 2024 Clinical Trials and Registries Symposium
-
ACTA 2024 Trial of the Year Awards
-
Webinar: National Clinical Trials Governance Framework: Update from sites that have been through accreditation
-
ACTA 2023 International Clinical Trials Symposium
-
Sector consultations – online discussion with ACTA
-
Economic Evaluation Alongside Adaptive Trials webinar – 22 November
-
Economic evaluation alongside cluster trial webinar
-
Clinical Quality Registries (CQR) SIG member webinar – Oct 2022
-
ACTA CEO update – October 2022
-
Improving clinical trial recruitment through innovative technologies
-
ACTA CEO update – August 2022
-
ACTA STInG 3 part webinar series on Data Transparency (DT)
-
Clinical Trials (CT) Socials
-
2022 ACTA ASM including the Australian Registry ASM
-
Clinical Trials 2022: National Tribute and Awards
-
Clinical Trials 2021: National Tribute and Award Ceremony
-
ACTA Advisory Council Meeting
-
ACTA Summit and Clinical Trials 2020 National Tribute and Award Ceremony
-
ARDC HeSANDA Australian Data Partnerships Program: Open Call
-
Continuity of Care Collaboration (CCC) Forum – Rural and Remote Health
-
ACTA International Clinical Trials Conference 2 – 5 October 2019
-
ACTA Advisory Council
-
ACTA Annual General Meeting